SFOSF - Shanghai Fosun Pharmaceutical reports 1H results
2023-08-30 11:42:12 ET
More on Shanghai Fosun Pharmaceutical
- Syneos, Fosun Pharma team up to launch lung cancer drug serplulimab in US
- BioNTech, Fosun Omicron-adapted booster gets approval in Hong Kong for aged 12 and above
- Sirona, Wanbang expand collaboration on TFC-039 for use in human health
- BioNTech rises as China agrees to offer COVID shot to expats
- Earnings data for Shanghai Fosun Pharmaceutical
- Dividend scorecard for Shanghai Fosun Pharmaceutical
For further details see:
Shanghai Fosun Pharmaceutical reports 1H results